Research studies are looking for volunteers just like you. Both healthy volunteers and participants with specific health conditions are needed to help answer important questions impacting the health of our friends and family. Join us to improve the health of others.

Study Categories

  • The Ohio State Lupus, Vasculitis and Glomerulonephritis Registry

    Official Title
    The Ohio State Lupus, Vasculitis and Glomerulonephritis Registry
    Purpose

    The purpose of the OSU Lupus and Vasculitis Registry is to obtain clinical and laboratory information about lupus and vasculitis and glomerulonephritis.

    Could this study be right for you?

    Patients at the Ohio State University Rheumatology and Lupus Clinic with one of the following diagnoses who are ages 18 years of age and older:
    - Systemic lupus erythematosus
    - Discoid lupus
    - Mixed connective tissue disorder
    - Undifferentiated connective tissue disorder
    - Wegener’s granulomatosus
    - Microscopic polyangiitis
    - Henoch-Schonlien Purpura
    - Takayasu’s arteritis
    - Giant cell/temporal arteritis
    - Churg-Strauss vasculitis
    - Other vasculitides
    - IgA nephropathy
    - Anti-GBM GN
    - Membranous GN
    - Minimal Change Disease
    - Focal Segmental Glomerulosclerosis

    Age Range
    18 and up
  • The REGENERATE Study - A study to evaluate the effectiveness and safety of a medication (Obeticholic Acid) for those with NASH (nonalcoholic steatohepatitis)

    Official Title
    A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
    Purpose

    This research study is for those who have nonalcoholic steatohepatitis (NASH) (meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue). Because of your condition, you may be eligible for a research study on an investigational drug for your condition. The Regenerate Study will assess the safety and effectiveness of the investigational medication obeticholic acid (OCA) compared to placebo in delaying specific medical conditions or health related issues that can occur in patients with nonalcoholic steatohepatitis (NASH) (meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue).

    Could this study be right for you?

    - Age 18 or older
    - Diagnosed with Stage 2 or 3 NASH (nonalcoholic steatohepatitis--meaning your liver is swollen and damaged because of a buildup of fat in your liver) and some liver fibrosis (which is damaged and scarred liver tissue).

    If you are eligible and decide to take part in this research study, you will need to complete 1 or 2 screening visits to see if you are eligible to participate in the study. Once the study doctor determines you can participate in the study, you will be asked to come back to the clinic 8 times (for the Month 0 [Day 1] Visit, the Month 1 Visit, the Month 3 Visit, and then every 3 months) for the first 18 months you are in the study and then 2 times per year (every 6 months) for each additional year you are in the study.

    Age Range
    18 and up
  • Vercise™ DBS Registry

    Official Title
    Registry of Deep Brain Stimulation with the VERCISE™ System: Vercise™ DBS Registry
    Purpose

    The purpose of this study is to record the personal experiences of those who have had Deep Brain Stimulation (DBS) using the Vercise™ System, for the treatment of Parkinson's Disease.

    Could this study be right for you?

    You may be eligible if you are:
    - At least 18 years of age
    - Planning to receive the currently available Vercise™ System and/or any new commercially approved parts such as leads, extension, Adaptor, CP, etc. that is works with the Vercise System

    Age Range
    18 and up